| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/05/2011 | US20110104077 Magnetic nanocomposite with multi-biofunctional groups and method for fabricating the same |
| 05/05/2011 | US20110104062 Biomarkers for Head-And-Neck Cancers and Precancers |
| 05/05/2011 | US20110104051 Chemically Modified Viral Capsids as Targeted Delivery Vectors for Diagnostic and Therapeutic Agents |
| 05/05/2011 | US20110104050 Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin |
| 05/05/2011 | US20110100361 Pressurised metered dose inhalers (mdi) |
| 05/05/2011 | CA2779615A1 Therapeutic nuclease compositions and methods |
| 05/05/2011 | CA2779601A1 Vaccine compositions and methods of use |
| 05/05/2011 | CA2779577A1 Stabilized protein formulations and use thereof |
| 05/05/2011 | CA2779316A1 Paclitaxel/steroidal compound |
| 05/05/2011 | CA2778689A1 Transdermal pharmaceutical compositions comprising active agents |
| 05/05/2011 | CA2776925A1 Liposome having inner water phase containing sulfobutyl ether cyclodextrin salt |
| 05/05/2011 | CA2776723A1 Sterilization of biodegradable hydrogels |
| 05/04/2011 | EP2316850A2 HASylated polypeptides, especially HASylated erythropoietin |
| 05/04/2011 | EP2316490A2 Methods and compositions for enhanced delivery of bioactive molecules |
| 05/04/2011 | EP2316487A1 Recombinant IL-9 antibodies & uses thereof |
| 05/04/2011 | EP2316485A1 Use of bispecific antibodies to regulate immune responses |
| 05/04/2011 | EP2316477A1 Immunogenic LHRH compositions and methods relating thereto |
| 05/04/2011 | EP2316475A1 Isolated tetrameric uricase |
| 05/04/2011 | EP2316473A1 Use of calcitonin in osteoarthritis |
| 05/04/2011 | EP2316471A1 Pharmaceutical formulations for sustained drug delivery |
| 05/04/2011 | EP2316469A1 Delivery system and methods for protecting and administering dextroamphetamine |
| 05/04/2011 | EP2316468A1 Delivery system and methods for protecting and administering dextroamphetamine |
| 05/04/2011 | EP2316454A1 Dosage form containing pantoprazole as active ingredient |
| 05/04/2011 | EP2316449A1 Stable pharmaceutical composition containing tranexamic acid and ascorbic acid |
| 05/04/2011 | EP2316443A1 Medicinal formulation for treating nail ailments |
| 05/04/2011 | EP2316439A1 Abuse resistant opioid containing transdermal systems |
| 05/04/2011 | EP2316431A1 Solid oral composition comprising a S1P receptor agonist and a sugar alcohol |
| 05/04/2011 | EP2316429A1 Matrix for sustained, invariant and independent release of active compounds |
| 05/04/2011 | EP2316428A1 Matrix for sustained, invariant and independent release of active compounds |
| 05/04/2011 | EP2316425A1 Liquid formulations comprising an active agent, glycerine and sorbitol |
| 05/04/2011 | EP2316421A1 Bupivacaine-containing injectable depot composition |
| 05/04/2011 | EP2316418A2 Transmucosal drug delivery system |
| 05/04/2011 | EP2316377A1 Drug-Delivery Endovascular Stent And Method For Treating Restenosis |
| 05/04/2011 | EP2315771A2 Glycopeptide constructs and uses thereof |
| 05/04/2011 | EP2315603A1 Polysaccharide-protein conjugates reversibly coupled via imine bonds |
| 05/04/2011 | EP2315580A1 Pharmaceutical formulations and methods for treating respiratory tract infections |
| 05/04/2011 | EP2123288B1 C70 fullerene-containing liposome, method for producing the same, and use of the same |
| 05/04/2011 | EP1957038B1 Particles |
| 05/04/2011 | EP1855661B1 Formulation for aviptadil |
| 05/04/2011 | EP1771199B9 Long-acting colloidal insulin formulation and preparation thereof |
| 05/04/2011 | EP1703899B1 Stabilised compositions of factor vii polypeptides |
| 05/04/2011 | EP1667726B1 Polyacetal drug conjugates as release system |
| 05/04/2011 | EP1587869B1 Membrane active polymers |
| 05/04/2011 | EP1494650B1 Pharmaceutical formulation comprising melatonin |
| 05/04/2011 | EP1465666B1 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy |
| 05/04/2011 | EP1446100B1 Injectable depot compositions and uses thereof |
| 05/04/2011 | EP1429742B1 Modified release dosage forms |
| 05/04/2011 | EP1414299B1 Method for making a homogenous doxorubicin -transferrin conjugate |
| 05/04/2011 | EP1404363B1 Adjuvant composition for mucosal and injection delivered vaccines |
| 05/04/2011 | EP1294746B1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 05/04/2011 | EP0952851B1 Anti-carious chewing gums, candies, gels, toothpastes and dentifrices |
| 05/04/2011 | EP0804166B1 Controlled release formulation (albuterol) |
| 05/04/2011 | CN1864822B Separating film for removing carbon monoxide, separating film assembly, method and device, an oxygen carrier with carbon monoxide removed and its pharmaceutical composition |
| 05/04/2011 | CN1863553B Process for preparing polysaccharide-protein conjugate vaccines |
| 05/04/2011 | CN1863504B Long term drug delivery devices with polyurethane based polymers |
| 05/04/2011 | CN1834001B Nano medicine self-guide, self-assembling quantumized electrical conductive joint and preparation method thereof |
| 05/04/2011 | CN1747656B Packaging and dispensing of rapid dissolve dosage form |
| 05/04/2011 | CN102046281A Microcapsules, method of producing the microcapsules and food and drink containing the microcapsules |
| 05/04/2011 | CN102046208A Composition for external application comprising transcription factor decoy as active ingredient |
| 05/04/2011 | CN102046207A Drug fusions and conjugates |
| 05/04/2011 | CN102046206A Fully synthetic albumin analogue |
| 05/04/2011 | CN102046205A Factor IX conjugates with extended half-lives |
| 05/04/2011 | CN102046204A Pharmaceutical compositions comprising a complex of aminocyclohexane derivatives and cyclodextrin |
| 05/04/2011 | CN102046203A Conjugated molecules comprising a peptide derived from the CD4 receptor coupled to a polyanion for the treatment of aids |
| 05/04/2011 | CN102046202A Stabilizing lipid compositions for oral pharmaceutical agents |
| 05/04/2011 | CN102046192A Compositions of GnRH related compounds and processes of preparation |
| 05/04/2011 | CN102046184A Cream-like O/W type emulsified composition and method for producing same |
| 05/04/2011 | CN102046178A Compositions and methods for skin care |
| 05/04/2011 | CN102046161A Novel depigmenting compositions in the form of a petroleum jelly-free and elastomer-free anhydrous composition comprising a solubilized phenolic derivative and a retinoid |
| 05/04/2011 | CN102046160A Novel anhydrous depigmenting compositions comprising a solubilized phenolic derivative |
| 05/04/2011 | CN102046159A Novel depigmenting compositions in the form of a petroleum jelly-free and elastomer-free anhydrous composition comprising a solubilized phenolic derivative |
| 05/04/2011 | CN102046157A Composition for transdermal delivery of cationic active agents |
| 05/04/2011 | CN102046150A Polymeric artificial tear system |
| 05/04/2011 | CN102040735A Aspartic acid-cyclodextrin copolymer and intermediate polymer, preparation methods of aspartic acid-cyclodextrin copolymer and intermediate polymer as well as application of aspartic acid-cyclodextrin copolymer |
| 05/04/2011 | CN102040675A Method for preparing hydroxypropyl-beta-cyclodextrin |
| 05/04/2011 | CN102040538A Crystalline polymorphic forms of monosodium N-[8-(2-hydroxybenzoyl)amino]caprylate |
| 05/04/2011 | CN102040537A Crystalline polymorphic forms of monosodium N-[8-(2-hydroxybenzoyl)amino]caprylate |
| 05/04/2011 | CN102040536A Crystalline polymorphic forms of monosodium N-[8-(2-hydroxybenzoyl)amino]caprylate |
| 05/04/2011 | CN102038963A Method for preparing a stabilised menthol emulsion |
| 05/04/2011 | CN102038958A Nano particle composition and application thereof |
| 05/04/2011 | CN102038957A Efficient cell nucleus targeted medicine vector and application thereof to preparing antineoplastic medicines |
| 05/04/2011 | CN102038956A Tumor nucleus target medicinal vector and application thereof in preparing anti-tumor medicament |
| 05/04/2011 | CN102038955A Method for preparing anticoagulant polysulfones material by fourier reaction grafting |
| 05/04/2011 | CN102038954A Water-soluble matrix suitable for preparing retinoic acid water-soluble preparation |
| 05/04/2011 | CN102038953A Composite for local anesthesia before ophthalmologic operation and preparation method and application thereof |
| 05/04/2011 | CN102038941A Application of protective antigen Omp25c to preparation of brucellosis vaccine |
| 05/04/2011 | CN102038939A Preparation method of adenosine triphosphate coenzyme insulin freeze-dried powder injection |
| 05/04/2011 | CN102038938A Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-beta |
| 05/04/2011 | CN102038933A Combination of cyclosporine A and alkylation serum albumin and preparation method thereof |
| 05/04/2011 | CN102038848A Mammary gland hyperplasia-treating capsule and preparation method thereof |
| 05/04/2011 | CN102038841A Chinese medicine capsules for treating chronic obstructive pulmonary disease (COPD) with stagnated phlegm obstructing lung and preparation method thereof |
| 05/04/2011 | CN102038783A Externally-used hot compress mud plaster for treating pains of human body and preparation method thereof |
| 05/04/2011 | CN102038778A Chinese medicinal composition with effects of relaxing meridians, activating collaterals, expelling wind and removing dampness and preparation method thereof |
| 05/04/2011 | CN102038766A Qingpeng liniment or lotion for relieving pain and eliminating swelling and preparation method thereof |
| 05/04/2011 | CN102038765A Qingpeng plaster for relieving pain and eliminating swelling and preparation method thereof |
| 05/04/2011 | CN102038764A Qingpeng powder or granules for stopping pain and diminishing swelling and preparation method thereof |
| 05/04/2011 | CN102038763A Qingpeng nasal preparation for stopping pain and diminishing swelling and preparation method thereof |
| 05/04/2011 | CN102038753A Formula of daphniphyllum calycinum and red-knees herb intestines and stomach-recovering dripping pills and preparation method of daphniphyllum calycinum-red-knees herb intestines and stomach-recovering dripping pills |
| 05/04/2011 | CN102038748A Traditional Chinese medicine transdermal ointment for treating bovine mastitis and preparation method thereof |
| 05/04/2011 | CN102038744A High-permeability environment-friendly high-efficiency skin disinfectant and preparation method thereof |